| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/14/2005 | US20050153974 Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors |
| 07/14/2005 | US20050153960 Substituted arylamine derivatives and methods of use |
| 07/14/2005 | US20050153941 Cell differntiation inhibiting agent, cell culture method using the same, culture medium, and cultured cell line |
| 07/14/2005 | US20050153938 Polyphosphonate derivatives for toothpaste compositions |
| 07/14/2005 | US20050153917 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 07/14/2005 | US20050153908 Using a 1,2,4-triazole compound; mixture with viricide |
| 07/14/2005 | US20050153907 Use of ribofuranose derivatives against inflammatory bowel diseases |
| 07/14/2005 | US20050153902 Inhibitors of integrin avb6 |
| 07/14/2005 | US20050153892 Compound B as an angiogenic agent in combination with human growth factors |
| 07/14/2005 | US20050153888 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells |
| 07/14/2005 | US20050153483 Carrier, method of manufacturing a carrier and an electronic device |
| 07/14/2005 | US20050153415 Lysin for use as tool in prevention of clostridial infection |
| 07/14/2005 | US20050153391 Polypeptides capable of binding to G protein coupled receptors as well as DNA encoding for such polypeptides; receptor binding assays; drug screening; obesity; prolactin production inhibitors |
| 07/14/2005 | US20050153018 pellets comprising compacted inner matrices containing viable microorganisms and moisture barrier coatings |
| 07/14/2005 | US20050152989 Method for treating irritable bowel syndrome |
| 07/14/2005 | US20050152926 For immunization and/or diagnosis; eg pneumonia, cardiovascular diseases, atherosclerosis, bronchitis |
| 07/14/2005 | US20050152921 Modified CpG oligodeoxynucleotide with improved immunoregulatory function |
| 07/14/2005 | US20050152875 administering interferon- beta (IFN- beta ) before organ grafting or surgery, for the prophylaxis of viral diseases such as hepatitis |
| 07/14/2005 | US20050152871 treating the subject in need with one or more chemokines and/or a DNA damaging agent inducing said chemokine(s); |
| 07/13/2005 | EP1553099A1 A riboflavin derivative and its manufacture and uses |
| 07/13/2005 | EP1553098A1 Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient |
| 07/13/2005 | EP1553096A1 Pyrazole compounds |
| 07/13/2005 | EP1553089A1 Antagonist of melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient |
| 07/13/2005 | EP1553087A1 Preventive and/or therapeutic drugs for inflammatory intestinal diseases |
| 07/13/2005 | EP1553085A1 Cyclic amine derivatives and their use as drugs |
| 07/13/2005 | EP1553084A1 Piperidine derivative, process for producing the same, and use |
| 07/13/2005 | EP1552838A1 Rubrofusarin glycoside-containing composition |
| 07/13/2005 | EP1552833A1 Stable solid preparations |
| 07/13/2005 | EP1552462A1 Methods of treating and preventing colitis involving il-13 and nk-t cells |
| 07/13/2005 | EP1551972A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 07/13/2005 | EP1551872A2 G-protein coupled receptors |
| 07/13/2005 | EP1551865A2 Hybrid molcules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 07/13/2005 | EP1551848A1 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 07/13/2005 | EP1551837A1 Phosphodiesterase 4 inhibitors |
| 07/13/2005 | EP1551803A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 07/13/2005 | EP1551763A1 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 07/13/2005 | EP1551434A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/13/2005 | EP1551412A1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 07/13/2005 | EP1551377A1 Edible phosphoprotein film |
| 07/13/2005 | EP1551369A2 Combination therapy for treatment of fibrotic disorders |
| 07/13/2005 | EP1463688B1 Use of an antimicrobial glass ceramic for dental care and oral hygiene |
| 07/13/2005 | EP1235802B1 Carbamate derivatives having muscarinic receptor antagonist activity |
| 07/13/2005 | EP1207860A4 Controlled release pellet formulation |
| 07/13/2005 | EP1178969B1 Gastrin and cholecystokinin receptor ligands |
| 07/13/2005 | EP1144364B1 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/13/2005 | EP1001976B1 Peptides having potassium channel opener activity |
| 07/13/2005 | CN1639322A Recombinant spores |
| 07/13/2005 | CN1639318A Antimicrobial composition |
| 07/13/2005 | CN1639317A Probiotic lactobacillus salivarius strains |
| 07/13/2005 | CN1639188A Hepta-, octa- and nonapeptides having antiangiogenic activity |
| 07/13/2005 | CN1639186A Inhibitors of kallikrein |
| 07/13/2005 | CN1639168A Bicyclic pyridine and pyrimidine P38 kinase inhibitors |
| 07/13/2005 | CN1639162A Pyrido(2, 1-a)isoquinoline derivatives as DPP-IV inhibitors |
| 07/13/2005 | CN1639161A Alkyne-aryl phosphodiesterase-4 inhibitors |
| 07/13/2005 | CN1639159A N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as DDP-IV inhibitors |
| 07/13/2005 | CN1639139A 5-phenylthiazole derivatives and use as PI3 kinase inhibitors |
| 07/13/2005 | CN1639132A N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/13/2005 | CN1639126A Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies |
| 07/13/2005 | CN1639125A New inhibitors of histone deacetylase |
| 07/13/2005 | CN1639124A Aminotetralin derivatives as muscarinic receptor antagonists |
| 07/13/2005 | CN1639123A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 07/13/2005 | CN1639121A 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity |
| 07/13/2005 | CN1638823A N-{5-[4-(4-methyl-piperazino-methyl)--benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents |
| 07/13/2005 | CN1638799A Human mast cell-expressed membrane proteins |
| 07/13/2005 | CN1638796A Methods of administering anti-TNF alpha antibodies |
| 07/13/2005 | CN1638788A Stabilized albumin preparaions |
| 07/13/2005 | CN1638787A Helicobacter pylori adhesion inhibitor |
| 07/13/2005 | CN1638776A Substituted 3-aryl-5-aryl-[1, 2, 4]-oxadiazoles and analogs |
| 07/13/2005 | CN1638765A Mediators of Hedgehog signaling pathways, compositions and uses related thereto |
| 07/13/2005 | CN1638762A Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists |
| 07/13/2005 | CN1638760A Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 07/13/2005 | CN1638757A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
| 07/13/2005 | CN1638753A Potentiation of therapeutic effects of fatty acids |
| 07/13/2005 | CN1638749A Ambroxol for treating painful conditions in the mouth and pharyngeal cavity |
| 07/13/2005 | CN1638747A Sustained release pharmaceutical composition |
| 07/13/2005 | CN1638746A Colonic release composition |
| 07/13/2005 | CN1638739A Compound for treating assuetude disturbance |
| 07/13/2005 | CN1638650A Composition improving age-related physiological deficits and increasing longevity |
| 07/13/2005 | CN1637142A Hepatitis B virus gene siRNA sequence and its use |
| 07/13/2005 | CN1637013A Modified cpg oligodeoxynucleotide with improved immunoregulatory function |
| 07/13/2005 | CN1636994A Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby |
| 07/13/2005 | CN1636983A Substituted heterocyclic compounds |
| 07/13/2005 | CN1636980A 二肽腈组织蛋白酶k抑制剂 Dipeptide nitrile cathepsin inhibitors k |
| 07/13/2005 | CN1636978A Pyrrolidinyl metalloprotease inhibitor and its application |
| 07/13/2005 | CN1636599A Medicine composition and kit for local narcosis or relieving pain |
| 07/13/2005 | CN1636588A Red yeast prepn containing active components of glossy ganoderma and its prepn process |
| 07/13/2005 | CN1636585A Chinese herbal medicine prepn for reversing liver cirrhosis |
| 07/13/2005 | CN1636576A Application of bioactive glass in preparing medicine for treating gastroduodenal ulcer |
| 07/13/2005 | CN1636572A Compositions and methods for treatment of mitochondrial diseases |
| 07/13/2005 | CN1636567A Piperazine derivative used as CCRS antagonist |
| 07/13/2005 | CN1636564A Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 07/13/2005 | CN1636561A Use of at-1 receptor antagonist for treating diseases associated with an increase of at-1 receptors |
| 07/13/2005 | CN1636463A Food product and process for manufacturing same |
| 07/13/2005 | CN1210281C Titanium derived compounds, rpeparation an use thereof |
| 07/13/2005 | CN1210273C Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 07/13/2005 | CN1210270C Novel use of phenylheteroalkylamine derivatives |
| 07/13/2005 | CN1210268C (Cyclo) alkyl substituted-gamma-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders |
| 07/13/2005 | CN1210263C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 07/13/2005 | CN1210251C Substituted nor bornylamion derivatives, method for production thereof, use thereof and medicaments containing said compounds |
| 07/13/2005 | CN1210066C Cloning pigs using donor nuclei from differentiated cells |